MTTS was established in 2004 with the goal of delivering innovative, cost-effective solutions for newborns in need of intensive medical care. The company offers a comprehensive suite of technologies for neonatal care - from CPAP machines that treat respiratory distress syndrome to phototherapy machines that treat neonatal jaundice. These devices help healthcare professionals to deliver a better quality of healthcare to a growing number of patients, and at a lower cost.
"It feels very good to launch our product in Southeast Asia where there is a great need to simplify diagnostics for newborns," says Magdalena Tharaldsen, Director International Business Development for Calmark. "MTTS provides equipment for light treatment, which complements our diagnostic instrument, ie they have the right customer segment and are already experts in neonatal jaundice.”
This information is information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 13 June 2022, 12:55 CEST.
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.